These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9324689)

  • 1. [2-Aryl-pyrrolo[2,1-b]benzothiazoles as a selective or dual inhibitors of cyclo-oxygenases and 5-lipoxygenases. 21. Non-steroidal anti-inflammatory agents].
    Dannhardt G; Kreher M; Nowe U; Schmitt S
    Pharmazie; 1997 Jun; 52(6):428-36. PubMed ID: 9324689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
    Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal antiinflammatory agents. Synthesis and enzyme inhibition of 2-[4-(heteroarylmethyl)phenyl] propanoic acids and analogues.
    Silvestri R; Pagnozzi E; Valoti M; Fusi F
    Farmaco; 1994 Oct; 49(10):625-32. PubMed ID: 7826468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal antiinflammatory agents, XVIII: C-5 functionalized 6,7-diphenyl-2,3-dihydro-1H-pyrrolizines as inhibitors of bovine cyclooxygenase and 5-lipoxygenase.
    Dannhardt G; Kiefer W
    Arch Pharm (Weinheim); 1994 Aug; 327(8):509-14. PubMed ID: 7944906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors.
    Kolasa T; Brooks CD; Rodriques KE; Summers JB; Dellaria JF; Hulkower KI; Bouska J; Bell RL; Carter GW
    J Med Chem; 1997 Feb; 40(5):819-24. PubMed ID: 9057869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)- 4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity.
    Unangst PC; Connor DT; Cetenko WA; Sorenson RJ; Kostlan CR; Sircar JC; Wright CD; Schrier DJ; Dyer RD
    J Med Chem; 1994 Jan; 37(2):322-8. PubMed ID: 8295221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of (E)-3-(4-methanesulfonylphenyl)-2-(aryl)acrylic acids as dual inhibitors of cyclooxygenases and lipoxygenases.
    Moreau A; Chen QH; Praveen Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7716-27. PubMed ID: 16931030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity.
    Hamer RR; Tegeler JJ; Kurtz ES; Allen RC; Bailey SC; Elliott ME; Hellyer L; Helsley GC; Przekop P; Freed BS; White J; Martin LL
    J Med Chem; 1996 Jan; 39(1):246-52. PubMed ID: 8568814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroidal anti-inflammatory agents, Part 19. E-2-pyrrolizin-5-yl acrylic acids as potent dual or selective inhibitors of bovine cyclooxygenase and 5-lipoxygenase.
    Dannhardt G; Kiefer W; Nowe U
    Arch Pharm (Weinheim); 1995 Sep; 328(9):681-6. PubMed ID: 7487426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
    Tordjman C; Sauveur F; Droual M; Briss S; Andre N; Bellot I; Deschamps C; Wierzbicki M
    Arzneimittelforschung; 2003; 53(11):774-9. PubMed ID: 14677373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition.
    Geronikaki AA; Lagunin AA; Hadjipavlou-Litina DI; Eleftheriou PT; Filimonov DA; Poroikov VV; Alam I; Saxena AK
    J Med Chem; 2008 Mar; 51(6):1601-9. PubMed ID: 18311898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of celecoxib analogues possessing a N-difluoromethyl-1,2-dihydropyrid-2-one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
    Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
    J Med Chem; 2009 Mar; 52(6):1525-9. PubMed ID: 19296694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
    Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
    Chen CS; Tan CM; Huang CH; Chang LC; Wang JP; Cheng FC; Chern JW
    Bioorg Med Chem; 2010 Jan; 18(2):597-604. PubMed ID: 20056549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of a cyclooxygenase (CO) inhibitor into a 5-lipoxygenase (LO) inhibitor: a general route to novel orally active anti-inflammatory and anti-allergy drugs.
    Kreft AF; Failli AA; Musser JH; Kubrak DM; Banker AL; Steffan R; Demerson CA; Nelson JA; Shah US; Gray W
    Drugs Exp Clin Res; 1991; 17(8):381-7. PubMed ID: 1822830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
    Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
    Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-inflammatory activity of chalcone derivatives.
    Herencia F; Ferrándiz ML; Ubeda A; Domínguez JN; Charris JE; Lobo GM; Alcaraz MJ
    Bioorg Med Chem Lett; 1998 May; 8(10):1169-74. PubMed ID: 9871729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple aromatic compounds containing propenone moiety show considerable dual COX/5-LOX inhibitory activities.
    Jahng Y; Zhao LX; Moon YS; Basnet A; Kim EK; Chang HW; Ju HK; Jeong TC; Lee ES
    Bioorg Med Chem Lett; 2004 May; 14(10):2559-62. PubMed ID: 15109651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adamantane derivatives of thiazolyl-N-substituted amide, as possible non-steroidal anti-inflammatory agents.
    Kouatly O; Geronikaki A; Kamoutsis C; Hadjipavlou-Litina D; Eleftheriou P
    Eur J Med Chem; 2009 Mar; 44(3):1198-204. PubMed ID: 18603333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.